Potent antitumor effect of 1-(2-deoxy-2-fluoro-4-thio-β-D- arabinofuranosyl)cytosine on peritoneal dissemination models of gastrointestinal cancers

Oncology Reports

Volumn 9, Issue 6, 2002, Pages 1319-1322

  Miura, Shinji ^a   Endo, Yoshio ^b   Yoshimura, Yuichi ^a   Endo, Mikari ^a   Yonemura, Yutaka ^b   Sasaki, Takuma ^b  

^a YAMASA CORPORATION   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

4 thio FAC; Advanced cancer; Gastrointestinal cancer; Nude mouse model; Peritoneal dissemination

Indexed keywords

1 (2 DEOXY 2 FLUORO 4 THIO ARABINOFURANOSYL)CYTOSINE; 1-(2-DEOXY-2-FLUORO-4-THIO-ARABINOFURANOSYL)CYTOSINE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIMETABOLITE; CYTARABINE; DRUG DERIVATIVE; FLOXURIDINE; FLUOROURACIL;

ADENOCARCINOMA; ANIMAL; ARTICLE; BODY WEIGHT; CANCER TRANSPLANTATION; CELL CULTURE; CELL DIVISION; COLON TUMOR; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; FEMALE; HUMAN; METASTASIS; MOUSE; NUDE MOUSE; ORAL DRUG ADMINISTRATION; PATHOLOGY; PERITONEUM TUMOR; STOMACH TUMOR; SURVIVAL RATE;

ADENOCARCINOMA; ADMINISTRATION, ORAL; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; BODY WEIGHT; CELL DIVISION; COLONIC NEOPLASMS; CYTARABINE; DISEASE MODELS, ANIMAL; FEMALE; FLOXURIDINE; FLUOROURACIL; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PERITONEAL NEOPLASMS; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR CELLS, CULTURED;

EID: 0036833835     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.6.1319     Document Type: Article

References (8)

1. Vanhoefer U, Rougier P, Wilke H, Ducreux MP, Lacave AJ, van Cutsem E, Planker M, Santos JG, Piedbois P, Paillot B, Bodenstein H, Schmoll HJ, Bleiberg H, Nordlinger B, Couvreur ML, Baron B and Wils JA: Final results of a randomized phase III triai of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol 18: 2648-2657, 2000. (Pubitemid 30465650)
2. Bajetta E, di Bartolomeo M, Somma L, del Vecchio M, Artale S, Zunino F, Bignami P, Magnani E and Buzzoni R: Doxifluridine in colorectal cancer patients resistant to 5-fluorouracil (5-FU) containing regimens. Eur J Cancer 33: 687-690, 1997. (Pubitemid 27223758)
3. Miura S, Yoshimura Y, Endo M, Machida H, Matsuda A, Tanaka M and Sasaki T: Antitumor activity of a novel orally effective nucleoside, 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine. Cancer Lett 129: 103-110, 1998. (Pubitemid 28375244)
4. Miura S, Yoshimura Y, Endo M, Satoh H, Machida H and Sasaki T: Comparison of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine with gemcitabine in its antitumor activity. Cancer Lett 144: 177-182, 1999. (Pubitemid 29457660)
5. Miura S, Yoshimura Y, Satoh H and Izuta S: The antitumor mechanism of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine: effects of its triphosphate on mammalian DNA polymerases. Jpn J Cancer Res 92: 562-567, 2001. (Pubitemid 32515098)
6. Yoshimura Y, Kitano K, Yamada K, Satoh H, Watanabe M, Miura S, Sakata S, Sasaki T and Matsuda A: A novel synthesis of 2′-modified 2′-deoxy-4′-thiocytidines from D-glucose. J Org Chem 62: 3140-3152, 1997.
7. Yonemura Y, Endo Y, Yamaguchi T, Fujimura T, Obata T, Kawamura T, Nojima N, Miyazaki I and Sasaki T: Mechanisms of the formation of the peritoneal dissemination in gastric cancer. Int J Oncol 8: 795-802, 1996. (Pubitemid 26109946)
8. Iwahashi M, Nakamori M, Tani M, Yamaue H, Sakaguchi S, Nakamura M, Ueda K, Ichiro M, Nishino E and Tanimura H: Complete response of highly advanced gastric cancer with peritoneal dissemination after new combined chemotherapy of S-1 and low-dose cisplatin: report of a case. Oncology 61: 16-22, 2001. (Pubitemid 32727583)